Victoria’s strong drug discovery capabilities are driven by world-class research and development and formidable collaborations across the ecosystem. A significant portion of Australian clinical trials take place here. However, drug discovery is a long and expensive process – and not always successful in commercialising.
AI tools have the potential to increase efficiency at every step, from early-stage computer simulations to late-stage trial design, patient recruitment and data analysis.
This event will explore computational drug discovery, AI-assisted progression of pre-clinical candidates to clinical trials and the benefits and challenges of AI throughout the development pipeline. Discussions and presentations from sector leaders will examine how AI can transform drug discovery by improving efficiency, reducing costs and accelerating development timelines.
Date: Thursday 27 June 2024
Time (AEST):
3:45 pm: Guest arrival and registration
4:00 pm – 5:30 pm: Presentations and Q&A
5:30 pm – 6:30 pm: Networking
Format: Hybrid – In person and live-streamed
Venue: Science Gallery Melbourne Theatre, 114 Grattan St, Carlton VIC 3053
Speakers:
Dr Herbert Treutlein, Co-Founder and Director, Sanoosa
Dr Jessica Holien, Vice Chancellor’s Research Fellow, School of Science, STEM College, RMIT University
Dr Lukasz Kowalczyk, Senior Scientist, Protein Production, AdAlta
Dr Lauren May, Heart Foundation Future Leader Fellow and co-lead GPCR Cardiac Biology Laboratory, Monash Institute of Pharmaceutical Sciences
Registration:
In-person: Members $85; Non Members $175
Online: Members $25; Non Members $45
This BioForum is sponsored by the State Government of Victoria
In-person registration:
Full refund given up to 7 days prior to the event
No refunds within 7 days of the event